Parkman Healthcare Partners LLC
Filing Date
Global Rank
#1,798
/ 8,608
▼ 18
· as of Mar 2026
Top Industry
Biotechnology
37.6%
3Y Alpha vs SPY
-8.7%
Period ended 3 months ago
Filed May 15, 2026 · 58d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+38.7%
SPY
+75.2%
Annualised alpha
-9.0%
Max drawdown
−32.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
89 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
5.3%
+0.6 pts
Top 5
20.3%
+0.9 pts
Top 10
34.9%
+1.9 pts
HHI
213
Diversified+16
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $964,562,654 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | +808,042 | 1,708,099 | $16,261,102 | |
| ATEC | Alphatec Holdings, Inc. | +546,582 | 823,763 | $8,962,541 | |
| CMPS | COMPASS Pathways plc | +454,939 | 554,411 | $3,065,892 | |
| BFLY | Butterfly Network, Inc. | +443,642 | 544,477 | $2,199,687 | |
| ABSI | Absci Corp | +406,154 | 1,864,806 | $5,594,418 | |
| XENE | Xenon Pharmaceuticals Inc. | +342,851 | 497,035 | $28,902,585 | |
| SNDX | Syndax Pharmaceuticals Inc | +327,488 | 901,511 | $21,059,296 | |
| AGIO | Agios Pharmaceuticals, Inc. | +303,921 | 403,525 | $13,651,250 | |
| PTCT | Ptc Therapeutics, Inc. | +271,185 | 431,364 | $29,388,829 | |
| EYPT | EyePoint, Inc. | +266,767 | 1,354,800 | $17,463,372 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +239,698 | 621,458 | $8,638,266 | |
| RCUS | Arcus Biosciences, Inc. | +238,672 | 1,207,274 | $26,077,118 | |
| OPRX | OptimizeRx Corp | +190,720 | 729,369 | $4,580,437 | |
| GPCR | Structure Therapeutics Inc. | +177,093 | 232,093 | $11,186,882 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +172,970 | 235,000 | $4,923,250 | |
| ASMB | Assembly Biosciences, Inc. | +161,870 | 411,227 | $11,411,549 | |
| ADPT | Adaptive Biotechnologies Corp | +150,085 | 551,815 | $7,659,192 | |
| ANIP | Ani Pharmaceuticals Inc | +135,575 | 280,575 | $21,576,217 | |
| IMNM | Immunome Inc. | +125,675 | 403,487 | $8,824,260 | |
| ZBH | Zimmer Biomet Holdings, Inc. | +118,508 | 269,557 | $24,373,343 | |
| URGN | UroGen Pharma Ltd. | +106,232 | 275,000 | $4,944,500 | |
| CAI | Caris Life Sciences, Inc. | +104,912 | 229,912 | $4,110,826 | |
| DXCM | Dexcom Inc | +102,347 | 689,822 | $43,320,821 | |
| WAY | Waystar Holding Corp. | +74,035 | 443,058 | $10,682,128 | |
| ANNX | Annexon, Inc. | +72,811 | 674,013 | $3,734,032 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | −406,024 | 259,184 | $12,479,709 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −230,140 | 557,936 | $10,913,228 | |
| MAZE | Maze Therapeutics, Inc. | −177,422 | 31,844 | $950,543 | |
| ADMA | Adma Biologics, Inc. | −117,557 | 82,443 | $742,811 | |
| SLDB | Solid Biosciences Inc. | −109,527 | 308,844 | $2,223,676 | |
| EWTX | Edgewise Therapeutics, Inc. | −104,862 | 322,828 | $10,169,082 | |
| RXST | RxSight, Inc. | −101,666 | 249,989 | $1,539,932 | |
| STOK | Stoke Therapeutics, Inc. | −93,636 | 336,519 | $10,957,058 | |
| MBX | MBX Biosciences, Inc. | −85,602 | 800,037 | $23,881,104 | |
| QDEL | QuidelOrtho Corp | −82,727 | 101,764 | $1,671,982 | |
| CVS | CVS HEALTH Corp | −62,906 | 387,306 | $27,816,316 | |
| APGE | Apogee Therapeutics, Inc. | −52,383 | 77,686 | $6,538,830 | |
| BSX | Boston Scientific Corp | −51,761 | 448,768 | $28,160,192 | |
| QURE | uniQure N.V. | −50,540 | 206,842 | $3,381,866 | |
| UPB | Upstream Bio, Inc. | −47,776 | 786,783 | $7,081,047 | |
| COO | Cooper Companies, Inc. | −35,452 | 89,883 | $6,426,634 | |
| NUVL | Nuvalent, Inc. | −30,634 | 88,078 | $9,023,591 | |
| MLYS | Mineralys Therapeutics, Inc. | −30,112 | 380,137 | $10,297,911 | |
| CSTL | Castle Biosciences Inc | −24,408 | 126,150 | $3,096,982 | |
| MCK | Mckesson Corp | −23,679 | 12,676 | $10,969,303 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −20,787 | 26,916 | $8,905,696 | |
| NBIX | Neurocrine Biosciences Inc | −15,643 | 99,069 | $13,051,350 | |
| WAT | Waters Corp /De/ | −15,452 | 26,447 | $7,875,916 | |
| THC | Tenet Healthcare Corp | −10,391 | 50,123 | $9,458,711 | |
| LIVN | LivaNova PLC | −6,947 | 403,965 | $25,676,015 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
17 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | 34,616 | $31,838,758 | |
| QGEN | Qiagen N.V. | 500,000 | $20,020,000 | |
| NVST | Envista Holdings Corp | 711,693 | $18,055,651 | |
| ABBV | AbbVie Inc. | 75,000 | $16,311,750 | |
| ILMN | Illumina, Inc. | 110,370 | $13,604,206 | |
| IDXX | Idexx Laboratories Inc /De | 15,000 | $8,428,350 | |
| ERAS | Erasca, Inc. | 406,702 | $6,580,438 | |
| TNGX | Tango Therapeutics, Inc. | 266,127 | $5,567,376 | |
| IRTC | iRhythm Holdings, Inc. | 40,125 | $4,735,552 | |
| MMED | MiniMed Group, Inc. | 317,324 | $4,734,474 | |
| CARL | Carlsmed, Inc. | 521,123 | $4,716,163 | |
| VIR | Vir Biotechnology, Inc. | 500,000 | $4,480,000 | |
| SUPN | Supernus Pharmaceuticals, Inc. | 85,062 | $4,396,854 | |
| COGT | Cogent Biosciences, Inc. | 100,126 | $3,853,849 | |
| AMRX | Amneal Pharmaceuticals, Inc. | 300,752 | $3,738,347 | |
| DRUG | Bright Minds Biosciences Inc. | 40,098 | $2,925,951 | |
| PLSE | Pulse Biosciences, Inc. | 50,125 | $1,082,198 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MASI | Masimo Corp | 200,000 | $26,012,000 | |
| TERN | Terns Pharmaceuticals, Inc. | 620,877 | $25,083,430 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 1,487,283 | $21,178,909 | |
| MTD | Mettler Toledo International Inc/ | 10,988 | $15,319,358 | |
| A | Agilent Technologies, Inc. | 100,000 | $13,607,000 | |
| DHR | Danaher Corp /De/ | 58,889 | $13,480,869 | |
| UNH | Unitedhealth Group Inc | 31,875 | $10,522,256 | |
| ACLX | Arcellx, Inc. | 128,111 | $8,352,837 | |
| DOCS | Doximity, Inc. | 162,276 | $7,185,581 | |
| BIIB | Biogen Inc. | 35,425 | $6,234,445 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 645,544 | $6,016,470 | |
| TMDX | TransMedics Group, Inc. | 45,174 | $5,495,417 | |
| SDGR | Schrodinger, Inc. | 298,939 | $5,345,029 | |
| VERA | Vera Therapeutics, Inc. | 100,564 | $5,092,560 | |
| PGEN | Precigen, Inc. | 1,002,826 | $4,191,812 | |
| SYRE | Spyre Therapeutics, Inc. | 124,485 | $4,078,128 | |
| MNKD | Mannkind Corp | 640,356 | $3,630,818 | |
| TVTX | Travere Therapeutics, Inc. | 86,297 | $3,297,408 | |
| CERT | Certara, Inc. | 348,750 | $3,072,487 | |
| PTGX | Protagonist Therapeutics, Inc | 25,973 | $2,268,481 | |
| ACHC | Acadia Healthcare Company, Inc. | 100,000 | $1,419,000 | |
| INSP | Inspire Medical Systems, Inc. | 15,000 | $1,383,450 | |
| SENS | Senseonics Holdings, Inc. | 206,793 | $1,141,497 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | 22,852 | $1,063,760 | |
| RPID | Rapid Micro Biosystems, Inc. | 354,465 | $1,027,948 | |
| No positions match the current search. | ||||
89 positions ·
$964,562,654 total
· as of Mar 31, 2026
Showing 1–50
of 89 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SYK |
Stryker Corp
Healthcare
|
Added | 154,771 | $50,856,202 | 5.27% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 689,822 | $43,320,821 | 4.49% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 1,835,506 | $36,948,735 | 3.83% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 156,561 | $32,852,760 | 3.41% | |
| LLY |
ELI LILLY & Co
Healthcare
|
NEW | 34,616 | $31,838,758 | 3.30% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 431,364 | $29,388,829 | 3.05% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 497,035 | $28,902,585 | 3.00% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 448,768 | $28,160,192 | 2.92% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Reduced | 387,306 | $27,816,316 | 2.88% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 1,207,274 | $26,077,118 | 2.70% | |
| LIVN |
LivaNova PLC
Healthcare
|
Reduced | 403,965 | $25,676,015 | 2.66% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Added | 269,557 | $24,373,343 | 2.53% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Reduced | 800,037 | $23,881,104 | 2.48% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 280,575 | $21,576,217 | 2.24% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 901,511 | $21,059,296 | 2.18% | |
| QGEN |
Qiagen N.V.
Healthcare
|
NEW | 500,000 | $20,020,000 | 2.08% | |
| NVST |
Envista Holdings Corp
Healthcare
|
NEW | 711,693 | $18,055,651 | 1.87% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Added | 1,354,800 | $17,463,372 | 1.81% | |
| ABBV |
AbbVie Inc.
Healthcare
|
NEW | 75,000 | $16,311,750 | 1.69% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 1,708,099 | $16,261,102 | 1.69% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 86,702 | $14,786,159 | 1.53% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 403,525 | $13,651,250 | 1.42% | |
| ILMN |
Illumina, Inc.
Healthcare
|
NEW | 110,370 | $13,604,206 | 1.41% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 167,155 | $13,385,772 | 1.39% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 99,069 | $13,051,350 | 1.35% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Reduced | 259,184 | $12,479,709 | 1.29% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 411,227 | $11,411,549 | 1.18% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 232,093 | $11,186,882 | 1.16% | |
| MCK |
Mckesson Corp
Healthcare
|
Reduced | 12,676 | $10,969,303 | 1.14% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 336,519 | $10,957,058 | 1.14% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 557,936 | $10,913,228 | 1.13% | |
| WAY |
Waystar Holding Corp.
Healthcare
|
Added | 443,058 | $10,682,128 | 1.11% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 380,137 | $10,297,911 | 1.07% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 322,828 | $10,169,082 | 1.05% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
Added | 1,721,264 | $9,983,331 | 1.04% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Reduced | 50,123 | $9,458,711 | 0.98% | |
| AORT |
Artivion, Inc.
Healthcare
|
Added | 252,014 | $9,228,752 | 0.96% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 88,078 | $9,023,591 | 0.94% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
Added | 823,763 | $8,962,541 | 0.93% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 26,916 | $8,905,696 | 0.92% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Added | 268,160 | $8,884,140 | 0.92% | |
| IMNM |
Immunome Inc.
Healthcare
|
Added | 403,487 | $8,824,260 | 0.91% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 621,458 | $8,638,266 | 0.90% | |
| IDXX |
Idexx Laboratories Inc /De
Healthcare
|
NEW | 15,000 | $8,428,350 | 0.87% | |
| WAT |
Waters Corp /De/
Healthcare
|
Reduced | 26,447 | $7,875,916 | 0.82% | |
| ADPT |
Adaptive Biotechnologies Corp
Healthcare
|
Added | 551,815 | $7,659,192 | 0.79% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Reduced | 786,783 | $7,081,047 | 0.73% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 406,702 | $6,580,438 | 0.68% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 77,686 | $6,538,830 | 0.68% | |
| COO |
Cooper Companies, Inc.
Healthcare
|
Reduced | 89,883 | $6,426,634 | 0.67% |